Birth Weight and Preterm Birth in Babies of Pregnant Women With Major Depression in Relation to Treatment With Antidepressants

Objective It is unclear whether antidepressant treatment has a preventive effect on negative neonatal outcomes due to major depression in pregnant women. The objective of the present study was to compare women with major depression treated with antidepressants, untreated women with major depression, and healthy women during pregnancy with respect to birth weight and preterm birth. Methods The study sample included a total of 23 women taking antidepressant medication, 36 women who were not taking antidepressant medication for major depression during pregnancy, and 30 healthy women. Major depression was diagnosed via the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Results The study groups were similar with respect to sociodemographic characteristics. Compared with infants of healthy control subjects, infants of untreated major depressed women had significantly lower birth weight and shorter gestational age at delivery. There is no significant difference between infants of major depressed women treated with antidepressants and infants of healthy subjects for these variables. Conclusions Our results suggest that antidepressants may have beneficial effects on the risk of low birth weight and preterm birth in the infants of depressed women.

[1]  M. Walsh,et al.  Fanaroff and Martin's neonatal-perinatal medicine : , 2015 .

[2]  A. Gilbert,et al.  Neonatal Outcomes After Late-Gestation Exposure to Selective Serotonin Reuptake Inhibitors , 2012, Journal of clinical psychopharmacology.

[3]  G. Koren,et al.  Antidepressant use during pregnancy: the benefit-risk ratio. , 2012, American journal of obstetrics and gynecology.

[4]  F. Uguz,et al.  Is hyperemesis gravidarum associated with mood, anxiety and personality disorders: a case-control study. , 2012, General hospital psychiatry.

[5]  G. Koren,et al.  Pregnancy Outcome After Exposure to Antidepressants and the Role of Maternal Depression: Results From the Norwegian Mother and Child Cohort Study , 2012, Journal of clinical psychopharmacology.

[6]  D. Davalos,et al.  Untreated prenatal maternal depression and the potential risks to offspring: a review , 2012, Archives of Women's Mental Health.

[7]  Francesc Botet,et al.  Obstetrical and neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitors: the relevance of dose. , 2011, Journal of affective disorders.

[8]  M. Black,et al.  Maternal depression and early childhood growth in developing countries: systematic review and meta-analysis. , 2011, Bulletin of the World Health Organization.

[9]  Tram Nguyen,et al.  Antidepressants in Pregnancy: a Systematic Review , 2010, The Australian and New Zealand journal of psychiatry.

[10]  Satish Iyengar,et al.  A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. , 2010, Archives of general psychiatry.

[11]  H. Malm,et al.  Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs). , 2010, Reproductive toxicology.

[12]  A. Buist,et al.  Neonatal Growth Outcomes at Birth and one Month Postpartum Following In Utero Exposure to Antidepressant Medication , 2010, The Australian and New Zealand journal of psychiatry.

[13]  F. Uguz,et al.  Is pregnancy associated with mood and anxiety disorders? A cross-sectional study. , 2010, General hospital psychiatry.

[14]  Lisa M Bodnar,et al.  Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. , 2009, The American journal of psychiatry.

[15]  P. Rucci,et al.  Axis I psychopathology and functional impairment at the third month of pregnancy: Results from the Perinatal Depression-Research and Screening Unit (PND-ReScU) study. , 2008, The Journal of clinical psychiatry.

[16]  Truls Østbye,et al.  Association of preterm birth with long-term survival, reproduction, and next-generation preterm birth. , 2008, JAMA.

[17]  R. Platt,et al.  Use of antidepressant medications during pregnancy: a multisite study. , 2008, American journal of obstetrics and gynecology.

[18]  V. Grech,et al.  Antenatal psychiatric morbidity in Maltese women. , 2007, General hospital psychiatry.

[19]  J. Mintz,et al.  Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. , 2007, The American journal of psychiatry.

[20]  Ariel J. Jaffa,et al.  Neurodevelopmental Outcome of Children With Intrauterine Growth Retardation: A Longitudinal, 10-Year Prospective Study , 2007, Journal of child neurology.

[21]  W. Holzgreve,et al.  Depression and anxiety during pregnancy: A risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature , 2007, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[22]  T. Einarson,et al.  Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes. , 2006, The Journal of clinical psychiatry.

[23]  C. Hertzman,et al.  Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. , 2006, Archives of general psychiatry.

[24]  M. Bixo,et al.  Depression and anxiety during pregnancy and six months postpartum: a follow‐up study , 2006, Acta obstetricia et gynecologica Scandinavica.

[25]  N. Kaciroti,et al.  Selective Serotonin Reuptake Inhibitor (SSRI) Use during Pregnancy and Effects on the Fetus and Newborn: A Meta-Analysis , 2005, Journal of Perinatology.

[26]  M. Bixo,et al.  Point prevalence of psychiatric disorders during the second trimester of pregnancy: a population-based study. , 2003, American journal of obstetrics and gynecology.

[27]  M. Kramer,et al.  The contribution of mild and moderate preterm birth to infant mortality. Fetal and Infant Health Study Group of the Canadian Perinatal Surveillance System. , 2000, JAMA.

[28]  L. Gottwald,et al.  [Intrauterine growth restriction]. , 2005, Przeglad lekarski.

[29]  Sho Tin Chen,et al.  National Institute of Mental Health , 2020, Definitions.

[30]  J. C. Ingram On the Obstetric Management of Prematurity , 1937 .